• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

• Eppendorf AG Announces Results for First Half of 2019 (2019-08-20)
  > At €66.7 million, income from operations is at prior-year level > Strong growth in all sales regions and product groups > Targets for the entire year are confirmed The globally active Eppendorf Group charted a strong first half-year in 2019 with a si...
• Bayer to Sell Animal Health Business to Elanco for $7.6b (2019-08-20)
  Exit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer’s focus as a global leader in life sciences U.S.-based company Elanco Animal Health has entered into a de...
• Nabriva: FDA Approves Xenleta (lefamulin) for CABP (2019-08-19)
  > First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP > XENLETA Expected to be Available mid-September 2019 > Conference call and webcast t...
• Juvenescence Closes $100m Series B Round (2019-08-19)
  Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to increase human longevity, is pleased to announce the successful closure of its $100 ...
• Genentech and Roche Appoint Levi Garraway as CMO (2019-08-19)
  Dr. Sandra Horning, Chief Medical Officer and Head of Global Product Development will retire on December 31, 2019. During her decade-long tenure with Roche and Genentech, Dr. Horning brought 15 new medicines to patients and tackled some of the world’s toughest dise...
• Roche: FDA Approves Rozlytrek (entrectinib) for Two Cancers (2019-08-16)
  > First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain > Roche’s first FDA-approved tumour-agnostic medicine Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food an...
• AskBio Acquires Synpromics Ltd. (2019-08-13)
  Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the lea...
• iTeos Therapeutics Appoints Matthew Call as COO (2019-08-13)
  iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, today announces the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development. Matthew joins iTeos ...
• Pharming Acquires Late Stage Orphan Drug from Novartis (2019-08-13)
  > CDZ173 is in a registration-enabling study for the treatment of APDS, an ultra-rare, debilitating disease with no approved treatment > APDS is treated by immunologists; the main physicians treating HAE and therefore already addressed by Pharming > Upfront p...
• Boehringer & MD Anderson Form Virtual Oncology RnD Center (2019-08-12)
  > New potential gastrointestinal and lung cancer therapies from Boehringer Ingelheim’s innovative oncology pipeline will be combined with the patient-driven drug-development capabilities at MD Anderson > The Center will initially investigate KRAS pathway inhibi...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.